Please wait

 

Exhibit 107

 

CALCULATION OF FILING FEE TABLES

 

Form S-3

(Form Type)

 

Traws Pharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  Security
Type		 Security Class Title Fee
Calculation
or Carry
Forward
Rule		 Amount
Registered (1)		 Proposed
Maximum
Offering
Price Per
Share (2)		 Proposed
Maximum
Aggregate
Offering
Price		 Fee Rate Amount of
Registration
Fee
Newly Registered Securities
Fees to be
Paid		 Equity Common Stock,
$0.01 par
value per
share		 Rule 457(c) 7,230,301 $8.19 $59,216,165.19 $0.00015310 $9,065.99
Fees
Previously
Paid		                
Carry Forward Securities
Carry
Forward
Securities		                
  Total Offering Amounts     $0.00015310 $9,065.99
  Total Fees Previously Paid       -
  Total Fees Offsets       -
  Net Fee Due       $9,065.99

 

(1)Represents the shares of common stock, par value $0.01 per share (“Common Stock”), of Traws Pharma, Inc. (the “Registrant”) that will be offered for resale by the selling stockholders pursuant to the prospectus contained in the Registration Statement on Form S-3 (the “Registration Statement”) to which this exhibit is attached. The Registration Statement registers an aggregate of 7,230,301 shares of Common Stock, which consist of (i) 3,311,052 shares of Common Stock issuable upon exercise of pre-funded warrants and (ii) 3,919,249 shares of Common Stock issuable upon exercise of Series A Warrants. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), the Registration Statement shall also cover any additional shares of Common Stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.

 

(2)Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act. The offering price per share and aggregate offering price are based upon the average of the high and low prices for the Common Stock, as reported on the Nasdaq Capital Market on January 10, 2025, a date within five business days prior to the filing of the Registration Statement.